Series B Life Science Companies

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Polymateria is a startup advancing science to help nature deal with plastic pollution.

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

InDevR develops and manufactures microarray technologies as well as novel solutions to support the life science industry.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.

Manifold offers machine learning tools for analyzing operational data and supporting decision making in industrial and energy use cases.

Chai Discovery develops artificial intelligence models that predict and reprogram biochemical molecule interactions.

Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

Sorcero is an AI and data intelligence platform that enhances insights and supports content creation in the life sciences sector.

Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.